Sumalpong, Tata Eldie E.

HRN: 25-69-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/15/2024
08/29/2024
IVT
4.5g
Q8
Nonhealing Wound, Both Feet
Waiting Final Action 
08/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/16/2024
08/23/2024
IV
300mg
Q8h
Nonhealing Wound
Waiting Final Action 
08/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/17/2024
08/24/2024
IV
600mg
Q8
Nonhealing Wound
Waiting Final Action 
09/01/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/01/2024
09/07/2024
IV
750mg
OD
PTB; CAP
Waiting Final Action 
09/08/2024
CEFTAZIDIME 1GM (VIAL)
09/08/2024
09/14/2024
IV
1gm
Q8
Infected DM Foot
Waiting Final Action 
09/10/2024
MUPIROCIN 2%, 15G (TUBE)
09/10/2024
09/17/2024
TOPICAL
Apply Thinly Over Affected Area
BID
Nonhealing Wound, B Feet
Waiting Final Action 
09/19/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/19/2024
09/21/2024
IV
600mg
Every 6 Hours
S/P AKA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: